|
[1] GUO ZY, CARBONE M, ZHANG X, et al. Improving the accu-racy of mesothelioma diagnosis in China[J]. J Thorac Oncol, 2017, 12 (4) :714-723.
|
|
[2] MUNKHOLM-LARSEN S, CAO CQ, YAN TD. Malignant peri-toneal mesothelioma[J]. World J Gastrointest Surg, 2009, 1 (1) :38-48.
|
|
[3] RAZA A, HUANG WC, TAKABE K. Advances in the manage-ment of peritoneal mesothelioma[J]. World J Gastroenterol, 2014, 20 (33) :11700-11712.
|
|
[4] ARNOLD DT, MASKELL NA. Biomarkers in mesothelioma[J].Ann Clin Biochem, 2018, 55 (1) :49-58.
|
|
[5] CLAIMON A, BANG JI, CHEON GJ, et al. Malignant perito-neal mesothelioma masquerades as peritoneal metastasis on (18) F-FDG PET/CT scans; A rare diagnosis that should notbe missed[J]. Nucl Med Mol Imaging, 2015, 49 (4) :325-328.
|
|
[6] ALEXANDER HR Jr, BURKE AP. Diagnosis and managementof patients with malignant peritoneal mesothelioma[J]. J Gas-trointest Oncol, 2016, 7 (1) :79-86.
|
|
[7] TANDON RT, JIMENEZ-CORTEZ Y, TAUB R, et al. Immuno-histochemistry in peritoneal mesothelioma:A single-centerexperience of 244 cases[J]. Arch Pathol Lab Med, 2018, 142 (2) :236-242.
|
|
[8] NAKAMURA K, NAKAYAMA K, NAGAOKA R, et al. The diag-nostic utility of PAX8 immunostaining of malignant peritonealmesothelioma presenting as serous ovarian carcinoma:A sin-gle-center report of two cases[J]. Oncol Lett, 2017, 13 (1) :263-266.
|
|
[9] MIRARABSHAHII P, PILLAI K, CHUA TC, et al. Diffuse malig-nant peritoneal mesothelioma-an update on treatment[J].Cancer Treat Rev, 2012, 38 (6) :605-612.
|
|
[10] LEE YK, JUN HJ, NAHM JH, et al. Therapeutic strategies forwell-differentiated papillary mesothelioma of the peritoneum[J]. Jpn J Clin Oncol, 2013, 43 (10) :996-1003.
|
|
[11] BEEBE-DIMMER JL, FRYZEK JP, YEE CL, et al. Mesothelio-ma in the United States:A Surveillance, Epidemiology, andEnd Results (SEER) -Medicare investigation of treatment pat-terns and overall survival[J]. Clin Epidemiol, 2016, 8:743-750.
|
|
[12] PILLAI K, POURGHOLAMI MH, CHUA TC, et al. Prognosticsignificance of Ki67 expression in malignant peritoneal meso-thelioma[J]. Am J Clin Oncol, 2015, 38 (4) :388-394.
|
|
[13] LI YC, KHASHAB T, TERHUNE J, et al. Preoperative throm-bocytosis predicts shortened survival in patients with malignantperitoneal mesothelioma undergoing operative cytoreductionand hyperthermic intraperitoneal chemotherapy[J]. Ann SurgOncol, 2017, 24 (8) :2259-2265.
|
DownLoad: